A network biology approach to prostate cancer

Molecular Systems Biology

Volumn 3, Issue , 2007, Pages

  Ergün, Ayla ^a   Lawrence, Carolyn A ^a   Kohanski, Michael A ^a,b   Brennan, Timothy A ^a   Collins, James J ^a  

^a Boston University   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Disease mediators; Prostate cancer; Reverse engineered gene networks; Systems biology

Indexed keywords

ANDROGEN RECEPTOR;

ARTICLE; CANCER CYTODIAGNOSIS; DISEASE MARKER; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC ENGINEERING; GENETIC MARKER; METASTASIS; MICROARRAY ANALYSIS; MOLECULAR GENETICS; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; GENE REGULATORY NETWORK; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

GENE REGULATORY NETWORKS; HUMANS; MALE; METABOLIC NETWORKS AND PATHWAYS; NEOPLASM METASTASIS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN;

EID: 33847008688     PISSN: 17444292     EISSN: 17444292     Source Type: Journal    
DOI: 10.1038/msb4100125     Document Type: Article

References (31)

1. Abate-Shen C, Banach-Petrosky WA, Sun X, Economides KD, Desai N, Gregg JP, Borowsky AD, Cardiff RD, Shen MM (2003) Nkx3.1; PTEN mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res 63: 3886-3890
2. Abate-Shen C, Shen M (2000) Molecular genetics of prostate cancer. Genes Dev 14: 2410-2434
3. Aprelikova O, Wood M, Tackett S, Chandramouli GV, Barrett JC (2006) Role of ETS transcription factors in the hypoxia-inducible factor-2 target gene selection. Cancer Res 66: 5641-5647
4. Balaji KC, Rao PS, Smith DJ, Louis S, Smith LM, Sherman S, Bacich D, O'Keefe D (2004) Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human prostate cancer cell line model. Urol Oncol 22: 313-320
5. Barabasi AL, Oltvai ZN (2004) Network biology: understanding the cell's functional organization. Nat Rev Genet 5: 101-113
6. Basso K, Margolin AA, Stolovitzky G, Klein U, Dalla-Favera R, Califano A (2005) Reverse engineering of regulatory networks in human B cells. Nat Genet 37: 382-390
7. Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P, Norton CR, Gridley T, Cardiff RD, Cunha GR, Abate-Shen C, Shen MM (1999) Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13: 966-977
8. Bowen C (2000) Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 60: 6111-6115
9. Burger MJ, Tebay MA, Keith PA, Samaratunga HM, Clements J, Lavin MF, Gardiner RA (2002) Expression analysis of delta-catenin and prostate-specific membrane antigen: their potential as diagnostic markers for prostate cancer. Int J Cancer 100: 228-237
10. di Bernardo D, Thompson MJ, Gardner TS, Chobot SE, Eastwood EL, Wojtovich AP, Elliott SJ, Schaus SE, Collins JJ (2005) Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat Biotechnol 23: 377-383
11. Edwards S, Campbell C, Flohr P, Shipley J, Giddings I, Te-Poele R, Dodson A, Foster C, Clark J, Jhavar S, Kovacs G, Cooper CS (2005) Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer. Br J Cancer 92: 376-381
12. Feldman BJ, Feldman D (2001) The development of androgen-independent prostate cancer. Nat Rev Cancer 1: 34-45
13. Gardner TS, Bernardo D, Lorenz D, Collins JJ (2003) Inferring genetic networks and identifying compound mode of action via expression profiling. Science 301: 102-105
14. Guillemette C, Lévesque E, Beaulieu M, Turgeon D, Hum DW, Bélanger A (1997) Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology 138: 2998-3005
15. Hobisch A, Culig Z, Radmayr C, Bartsch G, Klocker H, Hittmair A (1995) Distant metastases from prostatic carcinoma express androgen receptor protein. Cancer Res 55: 3068-3072
16. Hum DW, Belanger A, Levesque E, Barbier O, Beaulieu M, Albert C, Vallee M, Guillemette C, Tchernof A, Turgeon D, Dubois S. (1999) Characterization of UDP-glucuronosyltransferases active on steroid hormones. J Steroid Biochem Mol Biol 69: 413-423
17. Jung C, Kim RS, Zhang HJ, Lee SJ, Jeng MH (2004) HOXB13 induces growth suppression of prostate cancer cells as a repressor of hormone-activated androgen receptor signaling. Cancer Res 64: 9185-9192
18. Kinoshita Y, Kuratsukuri K, Newman N, Rovito PM, Kaumaya PT, Wang CY, Haas GP (2005) Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer. Prostate Cancer Prostatic Dis 8: 359-363
19. LaTulippe E, Satagopan J, Smith A, Scher H, Scardino P, Reuter V, Gerald WL (2002) Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease. Cancer Res 62: 4499-4506
20. Navarro D, Luzardo OP, Fernandez L, Chesa N, Diaz-Chico BN (2002) Transition to androgen independence in prostate cancer. J Steroid Biochem Mol Biol 81: 191-201
21. Nelson PS, Clegg N, Arnold H, Ferguson C, Bonham M, White J, Hood L, Lin B (2002) The program of androgen-responsive genes in neoplastic prostate epithelium. Proc Natl Acad Sci USA 99: 11890-11895
22. Schmittgen TD, Teske S, Vessella RL, True LD, Zakrajsek BA (2003) Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients. Int J Cancer 107: 323-329
23. Segal E, Friedman N, Kaminski N, Regev A, Koller D (2005) From signatures to models: understanding cancer using microarrays. Nat Genet 37 Suppl: S38-S45
24. Shultz WA (2005) Molecular Biology of Human Cancers. The Netherlands: Springer
25. Stanbrough M, Bubley GJ, Ross K, Golub TR, Rubin MA, Penning TM, Febbo PG, Balk SP (2006) Increased expression of genes converting
26. adrenal androgens to testosterone in androgen-independent prostate cancer. Cancer Res 66: 2815-2825
27. Taplin ME, Bubley GJ, Shuster TD, Frantz ME, Spooner AE, Ogata GK, Keer HN, Balk SP (1995) Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332: 1393-1398
28. Velasco AM, Gillis KA, Li Y, Brown EL, Sadler TM, Achilleos M, Greenberger LM, Frost P, Bai W, Zhang Y (2004) Identification and validation of novel androgen-regulated genes in prostate cancer. Endocrinology 145: 3913-3924
29. Weinberg RA, Hanahan D (2000) The hallmarks of cancer. Cell 100: 57-70
30. Yeang CH, Mak HC, McCuine S, Workman C, Jaakkola T, Ideker T (2005) Validation and refinement of gene-regulatory pathways on a network of physical interactions. Genome Biol 6: R62.1-R62.10
31. Zhao Y, Yamashita T, Ishikawa M (2005) Regulation of tumor invasion by HOXB13 gene overexpressed in human endometrial cancer. Oncol Rep 13: 721-726